https://news.medxy.ai/zh/cpap-therapy-blood-pressure-reduction-in-obstructive-sleep-apnea-patients/Medxy AIzh2026-08-04T14:13:17-07:00合并失眠可增强阻塞性睡眠呼吸暂停患者CPAP治疗后的降压效果 https://news.medxy.ai/ja/blood-pressure-reduction-with-cpap-therapy-in-obstructive-sleep-apnea-patients/Medxy AIja2026-08-04T14:13:02-07:00不眠症の併存は、閉塞性睡眠時無呼吸患者におけるCPAP療法の降圧効果を増強する https://news.medxy.ai/vi/cpap-therapy-in-obstructive-sleep-apnea-patients/Medxy AIvi2026-08-04T14:12:43-07:00Mất ngủ đi kèm làm tăng hiệu quả giảm huyết áp của liệu pháp CPAP ở bệnh nhân ngưng thở tắc nghẽn khi ngủ https://news.medxy.ai/comorbid-insomnia-amplifies-blood-pressure-reduction-with-cpap-therapy-in-obstructive-sleep-apnea-patients/Medxy AIen2026-08-04T14:12:01-07:00Comorbid Insomnia Amplifies Blood Pressure Reduction with CPAP Therapy in Obstructive Sleep Apnea Patients https://news.medxy.ai/zh/immune-of-copd-single-cell-rna-sequencing/Medxy AIzh2026-08-04T14:10:50-07:00解码COPD的免疫图谱：单细胞RNA测序揭示驱动疾病进展的促纤维化巨噬细胞与单核细胞生态位 https://news.medxy.ai/ja/immune-landscape-of-copd-single-cell-rna-sequencing/Medxy AIja2026-08-04T14:10:30-07:00COPDの免疫ランドスケープを読み解く：単一細胞RNAシーケンスが明らかにした、疾患進行を駆動する線維化促進性マクロファージと単球ニッチ https://news.medxy.ai/vi/the-immune-landscape-of-copd-single-cell-rna-sequencing/Medxy AIvi2026-08-04T14:10:10-07:00Giải mã bức tranh miễn dịch trong COPD: Giải trình tự RNA đơn bào hé lộ các quần thể đại thực bào và bạch cầu mono tiền xơ hóa thúc đẩy tiến triển bệnh https://news.medxy.ai/decoding-the-immune-landscape-of-copd-single-cell-rna-sequencing-reveals-profibrotic-macrophage-and-monocyte-niches-driving-disease-progression/Medxy AIen2026-08-04T14:09:22-07:00Decoding the Immune Landscape of COPD: Single-Cell RNA Sequencing Reveals Profibrotic Macrophage and Monocyte Niches Driving Disease Progression https://news.medxy.ai/zh/tumor-volume-regression-for-i-125-plaque-brachytherapy-for-posterior-uveal-melanoma/Medxy AIzh2026-08-04T14:08:08-07:00I-125敷贴近距离放射治疗后1年肿瘤体积回缩：后部葡萄膜黑色素瘤生存预后的重要指标 https://news.medxy.ai/ja/one-year-tumor-volume-regression-for-i-125-plaque-brachytherapy-for-posterior-uveal-melanoma/Medxy AIja2026-08-04T14:07:49-07:00I-125プラーク小線源治療後1年の腫瘍体積退縮は、後部ぶどう膜メラノーマの生存を予測する https://news.medxy.ai/vi/one-year-tumor-volume-regression-for-survival-in-i-125-plaque-brachytherapy-for-posterior-uveal-melanoma/Medxy AIvi2026-08-04T14:07:26-07:00Thoái lui thể tích khối u sau 1 năm: dấu ấn dự đoán sống còn trong xạ trị áp sát I-125 cho u hắc tố màng bồ đào vùng sau https://news.medxy.ai/one-year-tumor-volume-regression-as-a-predictor-of-survival-in-i-125-plaque-brachytherapy-for-posterior-uveal-melanoma/Medxy AIen2026-08-04T14:06:36-07:00One-Year Tumor Volume Regression as a Predictor of Survival in I-125 Plaque Brachytherapy for Posterior Uveal Melanoma https://news.medxy.ai/zh/unveiling-xxylt1-as-a-novel-mendelian-gene-in-inherited-retinal-dystrophy/Medxy AIzh2026-08-04T13:36:51-07:00GWAS 揭示 XXYLT1：遗传性视网膜营养不良中的新孟德尔致病基因 https://news.medxy.ai/unveiling-xxylt1-as-a-novel-mendelian-gene-in-inherited-retinal-dystrophy-insights-from-an-integrated-gwas-approach/Medxy AIen2026-08-04T13:35:15-07:00Unveiling XXYLT1 as a Novel Mendelian Gene in Inherited Retinal Dystrophy: Insights from an Integrated GWAS Approach https://news.medxy.ai/zh/determinants-of-endothelial-cell-density-one-year-after-dmek/Medxy AIzh2026-08-04T11:42:02-07:00DMEK术后1年内皮细胞密度的决定因素：来自糖尿病内皮角膜移植研究的启示 https://news.medxy.ai/determinants-of-endothelial-cell-density-one-year-after-dmek-insights-from-the-diabetes-endothelial-keratoplasty-study/Medxy AIen2026-08-04T11:40:31-07:00Determinants of Endothelial Cell Density One Year After DMEK: Insights from the Diabetes Endothelial Keratoplasty Study https://news.medxy.ai/zh/dried-blood-spot-pcr-detecting-congenital-cytomegalovirus-in-newborns/Medxy AIzh2026-08-04T11:40:04-07:00干血斑 PCR 检测用于筛查新生儿先天性巨细胞病毒：靶向检测队列研究结果 https://news.medxy.ai/ja/dried-blood-spot-pcr-for-detecting-congenital-cmv-in-newborns/Medxy AIja2026-08-04T11:39:48-07:00新生児の先天性CMVを見逃さないために：ターゲット検査で同定された症例に対する乾燥血液スポットPCRの有用性評価 https://news.medxy.ai/vi/dried-blood-spot-pcr-for-detecting-congenital-cytomegalovirus-in-newborns/Medxy AIvi2026-08-04T11:39:29-07:00Đánh giá PCR từ giọt máu khô trong phát hiện cytomegalovirus bẩm sinh ở trẻ sơ sinh được xác định bằng xét nghiệm mục tiêu https://news.medxy.ai/evaluating-dried-blood-spot-pcr-for-detecting-congenital-cytomegalovirus-in-newborns-identified-by-targeted-testing/Medxy AIen2026-08-04T11:38:46-07:00Evaluating Dried Blood Spot PCR for Detecting Congenital Cytomegalovirus in Newborns Identified by Targeted Testing https://news.medxy.ai/zh/the-mental-health-care-for-trauma-patients-at-risk-of-ptsd/Medxy AIzh2026-08-04T11:33:05-07:00弥合创伤患者PTSD心理照护缺口：来自社工的启示 https://news.medxy.ai/ja/the-mental-health-care-gap-for-trauma-patients-at-risk-of-ptsd/Medxy AIja2026-08-04T11:32:50-07:00PTSDリスクを有する外傷患者の精神保健ケア格差をどう埋めるか：ソーシャルワーカーの視点 https://news.medxy.ai/vi/the-mental-health-care-gap-for-trauma-patients-at-risk-of-ptsd-insights-from-social-workers/Medxy AIvi2026-08-04T11:32:31-07:00Thu hẹp khoảng cách chăm sóc sức khỏe tâm thần cho bệnh nhân chấn thương có nguy cơ PTSD: Góc nhìn từ nhân viên công tác xã hội https://news.medxy.ai/bridging-the-mental-health-care-gap-for-trauma-patients-at-risk-of-ptsd-insights-from-social-workers/Medxy AIen2026-08-04T11:31:47-07:00Bridging the Mental Health Care Gap for Trauma Patients at Risk of PTSD: Insights from Social Workers https://news.medxy.ai/zh/end-organ-damage-in-primary-hyperparathyroidism-prevalence-and-treatment/Medxy AIzh2026-08-04T11:31:17-07:00原发性甲状旁腺功能亢进症的靶器官损害：全国队列中的患病率、进展与治疗缺口 https://news.medxy.ai/ja/end-organ-damage-in-primary-hyperparathyroidism-prevalence-progression-and-treatment/Medxy AIja2026-08-04T11:30:59-07:00原発性副甲状腺機能亢進症における臓器障害：全国コホートでみた有病率、進行、治療のギャップ https://news.medxy.ai/vi/end-organ-damage-in-primary-hyperparathyroidism-prevalence-progression-and-treatment-gaps/Medxy AIvi2026-08-04T11:30:41-07:00Tổn thương cơ quan đích trong cường cận giáp nguyên phát: tỷ lệ hiện mắc, tiến triển và khoảng trống điều trị trong một đoàn hệ toàn quốc https://news.medxy.ai/end-organ-damage-in-primary-hyperparathyroidism-prevalence-progression-and-treatment-gaps-in-a-national-cohort/Medxy AIen2026-08-04T11:29:54-07:00End-Organ Damage in Primary Hyperparathyroidism: Prevalence, Progression, and Treatment Gaps in a National Cohort https://news.medxy.ai/zh/burn-depth-diagnosis-with-ai-ultrasound-imaging/Medxy AIzh2026-08-04T11:29:07-07:00AMBUSH-AI：借助人工智能与超声成像提升烧伤深度诊断 https://news.medxy.ai/ja/burn-depth-diagnosis-with-ai-and-ultrasound-imaging/Medxy AIja2026-08-04T11:28:50-07:00AMBUSH-AI：人工知能と超音波画像診断による熱傷深達度診断の新展開 https://news.medxy.ai/vi/burn-depth-diagnosis-with-artificial-intelligence-and-ultrasound-imaging/Medxy AIvi2026-08-04T11:28:30-07:00AMBUSH-AI: Nâng cao chẩn đoán độ sâu bỏng bằng trí tuệ nhân tạo và chẩn đoán hình ảnh siêu âm https://news.medxy.ai/ambush-ai-advancing-burn-depth-diagnosis-with-artificial-intelligence-and-ultrasound-imaging/Medxy AIen2026-08-04T11:27:32-07:00AMBUSH-AI: Advancing Burn Depth Diagnosis with Artificial Intelligence and Ultrasound Imaging https://news.medxy.ai/zh/gynecologic-oncology-decision-support-guideline-anchored-retrieval-augmented-generation-versus-baseline-literature/Medxy AIzh2026-08-04T11:26:59-07:00妇科肿瘤学决策支持再升级：指南锚定检索增强生成优于基础模型与文献型 AI https://news.medxy.ai/ja/gynecologic-oncology-decision-support-guideline-anchored-retrieval-augmented-generation-versus-baseline-and-literature/Medxy AIja2026-08-04T11:26:42-07:00婦人科腫瘍学の意思決定支援を強化：ガイドライン基盤RAGはベースラインと文献ベースAIをいかに上回ったか https://news.medxy.ai/vi/gynecologic-oncology-decision-support-impact-of-guideline-anchored-retrieval-augmented-generation-versus-baseline-and-literature/Medxy AIvi2026-08-04T11:26:23-07:00Nâng tầm hỗ trợ ra quyết định trong ung thư phụ khoa: RAG neo theo hướng dẫn vượt trội so với mô hình AI cơ bản và chỉ dựa trên y văn https://news.medxy.ai/enhanced-gynecologic-oncology-decision-support-impact-of-guideline-anchored-retrieval-augmented-generation-versus-baseline-and-literature-based-ai-models/Medxy AIen2026-08-04T11:25:34-07:00Enhanced Gynecologic Oncology Decision Support: Impact of Guideline-Anchored Retrieval-Augmented Generation Versus Baseline and Literature-Based AI Models https://news.medxy.ai/zh/multiple-pregnancies-on-subclinical-lv-function-in-women/Medxy AIzh2026-08-04T11:24:57-07:00多次妊娠对健康女性亚临床左心室功能的影响 https://news.medxy.ai/ja/multiple-pregnancies-on-subclinical-left-ventricular-function-in-women/Medxy AIja2026-08-04T11:24:41-07:00出産回数は妊娠中の潜在性左室機能に影響するのか？健康女性を対象とした検討 https://news.medxy.ai/vi/multiple-pregnancies-on-subclinical-left-ventricular-function-in-healthy-women/Medxy AIvi2026-08-04T11:24:22-07:00Số lần sinh con và ảnh hưởng tích lũy lên chức năng thất trái dưới lâm sàng ở phụ nữ khỏe mạnh https://news.medxy.ai/exploring-the-impact-of-multiple-pregnancies-on-subclinical-left-ventricular-function-in-healthy-women/Medxy AIen2026-08-04T11:23:36-07:00Exploring the Impact of Multiple Pregnancies on Subclinical Left Ventricular Function in Healthy Women https://news.medxy.ai/zh/antidepressant-continuation-during-pregnancy-and-postpartum-depression-risk/Medxy AIzh2026-08-04T11:21:07-07:00妊娠期继续使用抗抑郁药物，能否降低不同人群产后抑郁风险？ https://news.medxy.ai/ja/antidepressant-continuation-during-pregnancy-and-its-impact-on-postpartum-depression-risk/Medxy AIja2026-08-04T11:20:45-07:00妊娠中の抗うつ薬継続は産後うつ病を抑えられるか：多様な集団でみたリスクへの影響 https://news.medxy.ai/antidepressant-continuation-during-pregnancy-and-its-impact-on-postpartum-depression-risk-across-diverse-populations/Medxy AIen2026-08-04T11:19:20-07:00Antidepressant Continuation During Pregnancy and Its Impact on Postpartum Depression Risk Across Diverse Populations https://news.medxy.ai/ja/partnering-with-doulas-in-clinical-acog-2026/Medxy AIja2026-08-04T11:18:43-07:00臨床現場でのドゥーラ連携をどう進めるか：ACOG 2026年委員会声明の要点解説 https://news.medxy.ai/vi/doulas-in-clinical-settings-acog-2026/Medxy AIvi2026-08-04T11:18:08-07:00Hợp tác với Doula trong Cơ sở Lâm sàng: Giải thích Tuyên bố của Ủy ban ACOG 2026 https://news.medxy.ai/zh/partnering-with-doulas-in-clinical-settings-acog-2026/Medxy AIzh2026-08-04T11:17:35-07:00临床场景如何与分娩陪护人员协作？ACOG 2026 委员会声明要点解读 https://news.medxy.ai/partnering-with-doulas-in-clinical-settings-acog-2026-committee-statement-explained/Medxy AIen2026-08-04T11:14:53-07:00Partnering With Doulas in Clinical Settings: ACOG 2026 Committee Statement Explained https://news.medxy.ai/ja/weight-loss-dependent-and-independent-effects-of-survodutide-on-liver-outcomes-in-mash/Medxy AIja2026-08-04T11:13:51-07:00体重減少の関与を分解する：MASHにおけるSurvodutideの肝アウトカムへの影響を第2相媒介分析から読む https://news.medxy.ai/vi/disentangling-weight-loss-dependent-and-independent-effects-of-survodutide-on-liver-outcomes-in-mash/Medxy AIvi2026-08-04T11:13:30-07:00Tác động của survodutide đối với kết cục gan trong MASH: tách biệt vai trò phụ thuộc và không phụ thuộc vào giảm cân từ một phân tích trung gian pha 2 https://news.medxy.ai/disentangling-weight-loss-dependent-and-independent-effects-of-survodutide-on-liver-outcomes-in-mash-insights-from-a-phase-2-mediation-analysis/Medxy AIen2026-08-04T11:12:32-07:00Disentangling Weight Loss-Dependent and Independent Effects of Survodutide on Liver Outcomes in MASH: Insights from a Phase 2 Mediation Analysis https://news.medxy.ai/zh/rapid-skeletal-muscle-loss-in-cirrhosis/Medxy AIzh2026-08-04T11:11:47-07:00肝硬化患者快速骨骼肌丢失：预测因素、结局及临床管理启示 https://news.medxy.ai/ja/rapid-skeletal-muscle-loss-in-cirrhosis-outcomes/Medxy AIja2026-08-04T11:11:28-07:00肝硬変における骨格筋量の急速低下：予測因子、転帰、臨床管理への示唆 https://news.medxy.ai/vi/rapid-skeletal-muscle-loss-in-cirrhosis-predictors-outcomes/Medxy AIvi2026-08-04T11:11:07-07:00Mất khối cơ xương nhanh trong xơ gan: yếu tố dự báo, kết cục và ý nghĩa đối với quản lý lâm sàng https://news.medxy.ai/rapid-skeletal-muscle-loss-in-cirrhosis-predictors-outcomes-and-implications-for-clinical-management/Medxy AIen2026-08-04T11:10:13-07:00Rapid Skeletal Muscle Loss in Cirrhosis: Predictors, Outcomes, and Implications for Clinical Management https://news.medxy.ai/zh/reevaluating-acute-treatment-strategies-for-spontaneous-spinal-cord-infarction-2/Medxy AIzh2026-08-04T11:04:05-07:00自发性脊髓梗死急性期治疗策略再审视：来自倾向评分匹配研究的启示 https://news.medxy.ai/ja/reevaluating-acute-treatment-strategies-for-spontaneous-spinal-cord-infarction/Medxy AIja2026-08-04T11:03:46-07:00急性自然発症性脊髄梗塞の治療戦略を再考する：傾向スコアマッチド研究から得られた知見 https://news.medxy.ai/reevaluating-acute-treatment-strategies-for-spontaneous-spinal-cord-infarction-insights-from-a-propensity-score-matched-study/Medxy AIen2026-08-04T11:02:30-07:00Reevaluating Acute Treatment Strategies for Spontaneous Spinal Cord Infarction: Insights from a Propensity Score-Matched Study https://news.medxy.ai/zh/validating-vascog-2-wso-criteria-early-mri-detection-of-vascular-cognitive-impairment-and-mortality-risk-in-stroke-and-dementia-2/Medxy AIzh2026-08-04T10:58:49-07:00验证 VasCog-2-WSO 标准：MRI 早期识别卒中及痴呆阴性成人的血管性认知障碍与死亡风险 https://news.medxy.ai/ja/vascog-2-wso-criteria-early-mri-detection-of-vascular-cognitive-impairment-and-mortality-risk-in-stroke-and-dementia-free-adults/Medxy AIja2026-08-04T10:58:30-07:00VasCog-2-WSO基準の妥当性検証：脳卒中・認知症のない成人におけるMRI早期検出と死亡リスク https://news.medxy.ai/vi/validating-vascog-2-wso-criteria-early-mri-detection-of-vascular-cognitive-impairment-and-mortality-risk-in-stroke-and-dementia/Medxy AIvi2026-08-04T10:58:10-07:00Xác thực tiêu chuẩn VasCog-2-WSO: Phát hiện sớm bằng MRI tình trạng suy giảm nhận thức do mạch máu và nguy cơ tử vong ở người trưởng thành không có đột quỵ và sa sút trí tuệ https://news.medxy.ai/validating-vascog-2-wso-criteria-early-mri-detection-of-vascular-cognitive-impairment-and-mortality-risk-in-stroke-and-dementia-free-adults/Medxy AIen2026-08-04T10:57:15-07:00Validating VasCog-2-WSO Criteria: Early MRI Detection of Vascular Cognitive Impairment and Mortality Risk in Stroke- and Dementia-Free Adults https://news.medxy.ai/zh/serum-glial-fibrillary-acidic-protein-in-multiple-sclerosis-biomarker/Medxy AIzh2026-08-04T09:54:42-07:00多发性硬化中血清GFAP动态变化：解析疾病进展与治疗反应的生物标志物价值 https://news.medxy.ai/ja/serum-glial-fibrillary-acidic-protein-dynamics-in-multiple-sclerosis-biomarker/Medxy AIja2026-08-04T09:54:22-07:00多発性硬化症における血清GFAP動態：病勢進行と治療反応を読み解くバイオマーカーの新知見 https://news.medxy.ai/vi/serum-glial-fibrillary-acidic-protein-dynamics-in-multiple-sclerosis-biomarker-insights-into-disease-progression/Medxy AIvi2026-08-04T09:53:58-07:00Động học GFAP huyết thanh trong đa xơ cứng: giá trị dấu ấn sinh học đối với tiến triển bệnh và đáp ứng điều trị https://news.medxy.ai/serum-glial-fibrillary-acidic-protein-dynamics-in-multiple-sclerosis-biomarker-insights-into-disease-progression-and-therapeutic-response/Medxy AIen2026-08-04T09:52:19-07:00Serum Glial Fibrillary Acidic Protein Dynamics in Multiple Sclerosis: Biomarker Insights into Disease Progression and Therapeutic Response https://news.medxy.ai/zh/parkinsons-disease-genetics-across-diverse-ancestries-an-genetic-of-causal-and-risk-variants/Medxy AIzh2026-08-03T18:22:39-07:00帕金森病遗传学的多祖源差异：一项关注致病变异与风险变异及其转化意义的观察性研究 https://news.medxy.ai/ja/parkinsons-disease-genetics-across-diverse-ancestries-genetic-study-of-causal-and-risk-variants/Medxy AIja2026-08-03T18:22:18-07:00多祖先集団でみるパーキンソン病遺伝学：原因変異・リスク変異の観察研究とトランスレーショナルな示唆 https://news.medxy.ai/vi/parkinsons-disease-genetics-across-diverse-ancestries-an-observational-genetic-study-of-causal-and-risk-variants/Medxy AIvi2026-08-03T18:21:54-07:00Di truyền bệnh Parkinson ở các nguồn gốc tổ tiên đa dạng: nghiên cứu di truyền quan sát về các biến thể gây bệnh và biến thể nguy cơ với ý nghĩa chuyển giao lâm sàng https://news.medxy.ai/parkinsons-disease-genetics-across-diverse-ancestries-an-observational-genetic-study-of-causal-and-risk-variants-with-translational-implications/Medxy AIen2026-08-03T18:20:52-07:00Parkinson’s Disease Genetics Across Diverse Ancestries: An Observational Genetic Study of Causal and Risk Variants with Translational Implications https://news.medxy.ai/zh/prognostic-and-outcomes-in-brain-metastases-from-thyroid-carcinoma/Medxy AIzh2026-08-03T17:24:21-07:00非未分化滤泡细胞来源甲状腺癌脑转移的预后分层与临床结局：一项多中心回顾性研究 https://news.medxy.ai/ja/prognostic-and-outcomes-in-brain-metastases-from-nonanaplastic-follicular-cell-derived-thyroid-carcinoma/Medxy AIja2026-08-03T17:24:05-07:00非未分化濾胞細胞由来甲状腺癌の脳転移における予後層別化と転帰：多施設後ろ向き研究からの知見 https://news.medxy.ai/vi/prognostic-stratification-and-outcomes-in-brain-metastases-from-nonanaplastic-follicular-cell-derived-thyroid-carcinoma/Medxy AIvi2026-08-03T17:23:49-07:00Phân tầng tiên lượng và kết cục trong di căn não từ ung thư tuyến giáp biệt hóa nguồn gốc từ tế bào nang không thoái sản: góc nhìn từ một nghiên cứu hồi cứu đa trung tâm https://news.medxy.ai/prognostic-stratification-and-outcomes-in-brain-metastases-from-nonanaplastic-follicular-cell-derived-thyroid-carcinoma-insights-from-a-multicenter-retrospective-study/Medxy AIen2026-08-03T17:23:09-07:00Prognostic Stratification and Outcomes in Brain Metastases from Nonanaplastic Follicular Cell-Derived Thyroid Carcinoma: Insights from a Multicenter Retrospective Study https://news.medxy.ai/ja/metabolic-of-hepatic-pancreatic-and-abdominal-fat-depots-in-asian-indians-across-normoglycaemia-prediabetes-and-t2dm/Medxy AIja2026-08-03T17:18:55-07:00アジア系インド人における肝・膵・腹部脂肪蓄積と代謝異常：正常血糖、前糖尿病、2型糖尿病を横断して https://news.medxy.ai/vi/metabolic-implications-of-hepatic-pancreatic-and-abdominal-fat-depots-in-asian-indians-across-normoglycaemia-prediabetes-and-t2dm/Medxy AIvi2026-08-03T17:18:33-07:00Ý nghĩa chuyển hóa của mỡ gan, mỡ tụy và mỡ bụng ở người Ấn Độ châu Á qua các trạng thái đường huyết bình thường, tiền đái tháo đường và đái tháo đường type 2 https://news.medxy.ai/metabolic-implications-of-hepatic-pancreatic-and-abdominal-fat-depots-in-asian-indians-across-normoglycaemia-prediabetes-and-type-2-diabetes/Medxy AIen2026-08-03T17:17:52-07:00Metabolic Implications of Hepatic, Pancreatic, and Abdominal Fat Depots in Asian Indians Across Normoglycaemia, Prediabetes, and Type 2 Diabetes https://news.medxy.ai/zh/once-weekly-somapacitan-growth-hormone-therapy-for-turner-syndrome/Medxy AIzh2026-08-03T17:14:25-07:00每周一次somapacitan：Turner综合征女孩生长激素治疗的新选择 https://news.medxy.ai/ja/once-weekly-somapacitan-in-growth-hormone-therapy-for-turner-syndrome/Medxy AIja2026-08-03T17:14:09-07:00週1回ソマパシタン：ターナー症候群女児の成長ホルモン療法に新たな選択肢 https://news.medxy.ai/vi/once-weekly-somapacitan-in-growth-hormone-therapy-for-girls-with-turner-syndrome/Medxy AIvi2026-08-03T17:13:51-07:00Somapacitan Tiêm Hàng Tuần: Bước Tiến Mới Trong Điều Trị Hormone Tăng Trưởng Cho Bé Gái Mắc Hội Chứng Turner https://news.medxy.ai/once-weekly-somapacitan-a-new-frontier-in-growth-hormone-therapy-for-girls-with-turner-syndrome/Medxy AIen2026-08-03T17:13:11-07:00Once-Weekly Somapacitan: A New Frontier in Growth Hormone Therapy for Girls with Turner Syndrome https://news.medxy.ai/zh/melatonins-on-glucose-metabolism-amplified-by-mtnr1b-diabetes-variant/Medxy AIzh2026-08-03T16:55:20-07:00褪黑素如何影响葡萄糖代谢：MTNR1B 糖尿病风险变异会放大风险 https://news.medxy.ai/ja/melatonins-on-glucose-metabolism-risk-amplified-by-mtnr1b-diabetes-variant/Medxy AIja2026-08-03T16:55:04-07:00メラトニンが糖代謝に及ぼす影響：MTNR1B糖尿病リスク変異で増幅される危険性 https://news.medxy.ai/vi/melatonins-impact-on-glucose-metabolism-risk/Medxy AIvi2026-08-03T16:54:44-07:00Melatonin làm tăng nguy cơ rối loạn chuyển hóa glucose ở người mang biến thể MTNR1B liên quan đái tháo đường https://news.medxy.ai/melatonins-impact-on-glucose-metabolism-risk-amplified-by-mtnr1b-diabetes-variant/Medxy AIen2026-08-03T16:54:08-07:00Melatonin’s Impact on Glucose Metabolism: Risk Amplified by MTNR1B Diabetes Variant https://news.medxy.ai/zh/survival-outcomes-in-asymptomatic-with-degenerative-mitral-regurgitation/Medxy AIzh2026-08-03T16:47:46-07:00无症状退行性二尖瓣反流患者的长期生存结局：一项25年前瞻性队列研究的启示 https://news.medxy.ai/ja/survival-outcomes-in-asymptomatic-patients-with-degenerative-mitral-regurgitation/Medxy AIja2026-08-03T16:47:30-07:00無症候性退行性僧帽弁逆流患者の長期生存転帰：25年前向きコホート研究から見えたこと https://news.medxy.ai/vi/long-term-survival-outcomes-in-asymptomatic-patients-with-degenerative-mitral-regurgitation/Medxy AIvi2026-08-03T16:47:13-07:00Kết cục sống còn dài hạn ở bệnh nhân không có triệu chứng mắc hở van hai lá thoái hóa: Góc nhìn từ nghiên cứu đoàn hệ tiến cứu 25 năm https://news.medxy.ai/long-term-survival-outcomes-in-asymptomatic-patients-with-degenerative-mitral-regurgitation-insights-from-a-25-year-prospective-cohort-study/Medxy AIen2026-08-03T16:46:35-07:00Long-Term Survival Outcomes in Asymptomatic Patients with Degenerative Mitral Regurgitation: Insights from a 25-Year Prospective Cohort Study https://news.medxy.ai/zh/electrophysiology-guided-surgical-ablation-during-pulmonary-valve-replacement-in-managing-arrhythmia-risk-in-adults/Medxy AIzh2026-08-03T16:34:25-07:00肺动脉瓣置换术中的电生理指导手术消融：改善已修复法洛四联症成人心律失常风险管理的新策略 https://news.medxy.ai/ja/electrophysiology-guided-surgical-ablation-during-pulmonary-valve-replacement-a-paradigm-shift-in-managing-arrhythmia-risk-in-adults/Medxy AIja2026-08-03T16:34:07-07:00肺動脈弁置換術における電気生理学ガイド下外科的アブレーション：修復後ファロー四徴症成人の不整脈リスク管理を変える新たな視点 https://news.medxy.ai/electrophysiology-guided-surgical-ablation-during-pulmonary-valve-replacement-a-paradigm-shift-in-managing-arrhythmia-risk-in-adults-with-repaired-tetralogy-of-fallot/Medxy AIen2026-08-03T16:33:00-07:00Electrophysiology-Guided Surgical Ablation During Pulmonary Valve Replacement: A Paradigm Shift in Managing Arrhythmia Risk in Adults with Repaired Tetralogy of Fallot https://news.medxy.ai/vi/equivalence-of-nongated-and-gated-coronary-artery-calcium-scoring-in-predicting-cardiovascular-events/Medxy AIvi2026-08-03T15:36:22-07:00Tương đương giữa chấm điểm vôi hóa động mạch vành trên CT ngực không đồng bộ và đồng bộ nhịp tim trong dự báo biến cố tim mạch: Dữ liệu từ MESA đợt khám 5 https://news.medxy.ai/equivalence-of-nongated-and-gated-coronary-artery-calcium-scoring-in-predicting-cardiovascular-events-insights-from-mesa-exam-5-4/Medxy AIen2026-08-03T15:35:22-07:00Equivalence of Nongated and Gated Coronary Artery Calcium Scoring in Predicting Cardiovascular Events: Insights from MESA Exam 5 https://news.medxy.ai/vi/dual-immune-checkpoint-inhibition-with-cemiplimab-and-fianlimab-enhances-neoadjuvant-chemotherapy-response-in-early-stage-high-risk-erbb2-negative-breast-cancer/Medxy AIvi2026-08-03T14:39:15-07:00Phối hợp ức chế kép điểm kiểm soát miễn dịch với cemiplimab và fianlimab giúp tăng đáp ứng hóa trị tân bổ trợ ở ung thư vú giai đoạn sớm nguy cơ cao âm tính với ERBB2: Góc nhìn từ thử nghiệm I-SPY2 https://news.medxy.ai/dual-immune-checkpoint-inhibition-with-cemiplimab-and-fianlimab-enhances-neoadjuvant-chemotherapy-response-in-early-stage-high-risk-erbb2-negative-breast-cancer-insights-from-the-i-spy2-trial/Medxy AIen2026-08-03T14:38:26-07:00Dual Immune Checkpoint Inhibition with Cemiplimab and Fianlimab Enhances Neoadjuvant Chemotherapy Response in Early-Stage High-Risk ERBB2-Negative Breast Cancer: Insights from the I-SPY2 Trial https://news.medxy.ai/zh/septorhinoplasty-outcomes-the-role-of-internal-nasal-dilators-in-nostril-symmetry-and-function/Medxy AIzh2026-08-03T10:47:21-07:00鼻中隔鼻整形术后效果提升：鼻腔内扩张器在改善鼻孔对称性与功能中的作用 https://news.medxy.ai/vi/septorhinoplasty-outcomes-the-role-of-internal-nasal-dilators-in-improving-nostril-symmetry-and-function/Medxy AIvi2026-08-03T10:46:45-07:00Tối ưu hóa kết quả septorhinoplasty: Vai trò của bộ giãn mũi trong trong cải thiện đối xứng lỗ mũi và chức năng https://news.medxy.ai/enhancing-septorhinoplasty-outcomes-the-role-of-internal-nasal-dilators-in-improving-nostril-symmetry-and-function/Medxy AIen2026-08-03T10:45:56-07:00Enhancing Septorhinoplasty Outcomes: The Role of Internal Nasal Dilators in Improving Nostril Symmetry and Function https://news.medxy.ai/zh/autoaugmentation-and-implant-based-augmentation-mastopexy-after-massive-weight-loss/Medxy AIzh2026-08-03T10:45:20-07:00大量减重后自体组织增量乳房上提术与假体增量乳房上提术比较：结局及临床意义 https://news.medxy.ai/ja/autoaugmentation-and-implant-based-augmentation-mastopexy-after-massive-weight-loss-outcomes/Medxy AIja2026-08-03T10:45:01-07:00大幅減量後の乳房形成術：自己組織増大とインプラント併用術の成績を比較する https://news.medxy.ai/vi/autoaugmentation-and-implant-based-augmentation-mastopexy-after-massive-weight-loss-outcomes-and-clinical-implications/Medxy AIvi2026-08-03T10:44:39-07:00Treo tuyến vú tự thân hay dùng implant sau giảm cân nhiều: kết quả và ý nghĩa lâm sàng https://news.medxy.ai/comparing-autoaugmentation-and-implant-based-augmentation-mastopexy-after-massive-weight-loss-outcomes-and-clinical-implications/Medxy AIen2026-08-03T10:43:53-07:00Comparing Autoaugmentation and Implant-Based Augmentation Mastopexy After Massive Weight Loss: Outcomes and Clinical Implications https://news.medxy.ai/zh/socioeconomic-status-and-comorbidity-icu-mortality/Medxy AIzh2026-08-03T10:28:47-07:00社会经济地位与合并症如何影响ICU死亡率：来自荷兰全国队列的研究启示 https://news.medxy.ai/ja/socioeconomic-status-and-comorbidity-on-icu-mortality/Medxy AIja2026-08-03T10:28:31-07:00社会経済的地位と併存疾患がICU死亡率に及ぼす影響――オランダ全国コホート研究からの示唆 https://news.medxy.ai/vi/socioeconomic-status-and-comorbidity-influence-on-icu-mortality/Medxy AIvi2026-08-03T10:28:12-07:00Tình trạng kinh tế – xã hội và bệnh đồng mắc ảnh hưởng đến tử vong tại ICU: Dữ liệu từ một đoàn hệ toàn quốc ở Hà Lan https://news.medxy.ai/socioeconomic-status-and-comorbidity-influence-on-icu-mortality-insights-from-a-dutch-nationwide-cohort/Medxy AIen2026-08-03T10:27:25-07:00Socioeconomic Status and Comorbidity Influence on ICU Mortality: Insights from a Dutch Nationwide Cohort https://news.medxy.ai/zh/social-care-in-pediatric-emergency-department/Medxy AIzh2026-08-03T10:08:35-07:00提升儿科急诊中的社会照护：一项混合方法随机对照试验的启示 https://news.medxy.ai/ja/social-care-in-the-pediatric-emergency-department/Medxy AIja2026-08-03T10:08:16-07:00小児救急外来における社会的ケアを高めるには：混合研究法ランダム化比較試験からの示唆 https://news.medxy.ai/vi/enhancing-social-care-in-the-pediatric-emergency-department/Medxy AIvi2026-08-03T10:07:55-07:00Tăng cường chăm sóc xã hội tại khoa cấp cứu nhi khoa: Những phát hiện từ một thử nghiệm ngẫu nhiên có đối chứng với phương pháp hỗn hợp https://news.medxy.ai/enhancing-social-care-in-the-pediatric-emergency-department-insights-from-a-mixed-method-randomized-controlled-trial/Medxy AIen2026-08-03T10:06:48-07:00Enhancing Social Care in the Pediatric Emergency Department: Insights from a Mixed-Method Randomized Controlled Trial https://news.medxy.ai/zh/language-barriers-and-emergency-department-crowding-in-wait-times/Medxy AIzh2026-08-03T10:04:40-07:00语言障碍与急诊拥挤：学术医疗中心等待时间差异的揭示 https://news.medxy.ai/ja/language-barriers-and-emergency-department-crowding-disparities-in-wait-times/Medxy AIja2026-08-03T10:04:23-07:00言語の壁と救急外来の混雑：学術医療センターにおける待機時間格差の実態 https://news.medxy.ai/vi/language-barriers-and-emergency-department-crowding-uncovering-disparities-in-wait-times/Medxy AIvi2026-08-03T10:04:04-07:00Rào cản ngôn ngữ và quá tải khoa Cấp cứu: Phát hiện chênh lệch thời gian chờ tại một trung tâm y khoa học thuật https://news.medxy.ai/language-barriers-and-emergency-department-crowding-uncovering-disparities-in-wait-times-at-an-academic-medical-center/Medxy AIen2026-08-03T10:03:00-07:00Language Barriers and Emergency Department Crowding: Uncovering Disparities in Wait Times at an Academic Medical Center https://news.medxy.ai/zh/hepa-filters-in-care-homes-no-reduction-in-respiratory-infections/Medxy AIzh2026-08-03T09:53:25-07:00护理院安装HEPA过滤器难见冬季呼吸道感染下降：AFRI-c试验结果 https://news.medxy.ai/vi/hepa-filters-in-care-homes-no-reduction-in-winter-respiratory-infections/Medxy AIvi2026-08-03T09:52:48-07:00Bộ lọc HEPA tại viện dưỡng lão: AFRI-c không ghi nhận giảm nhiễm trùng hô hấp mùa đông https://news.medxy.ai/hepa-filters-in-care-homes-no-reduction-in-winter-respiratory-infections-according-to-afri-c-trial/Medxy AIen2026-08-03T09:51:42-07:00HEPA Filters in Care Homes: No Reduction in Winter Respiratory Infections According to AFRI-c Trial https://news.medxy.ai/zh/glp-1-receptor-agonists-versus-oral-agents-for-insulin-discontinuation-in-t2dm/Medxy AIzh2026-08-03T09:51:09-07:00GLP-1受体激动剂与口服药物用于2型糖尿病胰岛素停用：来自退伍军人健康管理局目标试验模拟的研究洞见 https://news.medxy.ai/ja/glp-1-receptor-agonists-versus-oral-agents-for-insulin-discontinuation-in-type-2-diabetes/Medxy AIja2026-08-03T09:50:51-07:002型糖尿病におけるインスリン中止は促進されるか：GLP-1受容体作動薬と経口薬を比較した退役軍人医療システムの解析 https://news.medxy.ai/vi/evaluating-glp-1-receptor-agonists-versus-oral-agents-for-insulin-discontinuation-in-type-2-diabetes/Medxy AIvi2026-08-03T09:50:31-07:00Chất chủ vận thụ thể GLP-1 có giúp ngừng insulin tốt hơn thuốc uống ở đái tháo đường type 2? Dữ liệu từ một nghiên cứu mô phỏng thử nghiệm lâm sàng ở cựu chiến binh https://news.medxy.ai/evaluating-glp-1-receptor-agonists-versus-oral-agents-for-insulin-discontinuation-in-type-2-diabetes-insights-from-a-veterans-health-administration-target-trial-emulation/Medxy AIen2026-08-03T09:48:35-07:00Evaluating GLP-1 Receptor Agonists Versus Oral Agents for Insulin Discontinuation in Type 2 Diabetes: Insights from a Veterans Health Administration Target Trial Emulation https://news.medxy.ai/zh/secondary-autoimmune-and-inflammatory-diseases-post-allogeneic-hematopoietic-stem-cell-transplantation-risk-factors/Medxy AIzh2026-08-02T20:05:18-07:00异基因造血干细胞移植后继发性自身免疫与炎症性疾病：来自EBMT登记研究的发生率、危险因素及临床结局 https://news.medxy.ai/ja/secondary-autoimmune-and-inflammatory-diseases-post-allogeneic-hematopoietic-stem-cell-transplantation-incidence-risk-factors/Medxy AIja2026-08-02T20:05:00-07:00同種造血幹細胞移植後の続発性自己免疫・炎症性疾患：EBMTレジストリからみた発症率・リスク因子・臨床転帰 https://news.medxy.ai/vi/secondary-autoimmune-and-inflammatory-diseases-post-allogeneic-hematopoietic-stem-cell-transplantation-incidence-risk-factors-and-clinical-outcomes/Medxy AIvi2026-08-02T20:04:43-07:00Bệnh tự miễn và viêm thứ phát sau ghép tế bào gốc tạo máu dị thân: Tỷ lệ mắc, yếu tố nguy cơ và kết cục lâm sàng từ sổ đăng ký EBMT https://news.medxy.ai/secondary-autoimmune-and-inflammatory-diseases-post-allogeneic-hematopoietic-stem-cell-transplantation-incidence-risk-factors-and-clinical-outcomes-from-the-ebmt-registry/Medxy AIen2026-08-02T20:03:43-07:00Secondary Autoimmune and Inflammatory Diseases Post-Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, and Clinical Outcomes from the EBMT Registry https://news.medxy.ai/zh/cytogenetic-into-multiple-myeloma-despite-mrd-negativity-post-autologous-stem-cell-transplant/Medxy AIzh2026-08-02T20:02:24-07:00自体干细胞移植后即便 MRD 阴性，多发性骨髓瘤结局仍受细胞遗传学影响 https://news.medxy.ai/ja/cytogenetic-into-multiple-myeloma-outcomes-despite-mrd-negativity-post-autologous-stem-cell-transplant/Medxy AIja2026-08-02T20:02:05-07:00MRD陰性でも残る多発性骨髄腫のリスク：自家移植後の細胞遺伝学的所見が示す予後差 https://news.medxy.ai/cytogenetic-insights-into-multiple-myeloma-outcomes-despite-mrd-negativity-post-autologous-stem-cell-transplant/Medxy AIen2026-08-02T20:00:34-07:00Cytogenetic Insights into Multiple Myeloma Outcomes Despite MRD Negativity Post-Autologous Stem Cell Transplant https://news.medxy.ai/zh/cd19-car-t-cell-therapy-without-lymphodepletion-in-pemphigus-vulgaris/Medxy AIzh2026-08-02T19:57:29-07:00无需淋巴清除的 CD19 CAR T 细胞治疗在寻常型天疱疮中展现希望：RESET-PV 试验带来新启示 https://news.medxy.ai/vi/cd19-car-t-cell-therapy-without-lymphodepletion-shows-promise-in-pemphigus-vulgaris/Medxy AIvi2026-08-02T19:56:54-07:00Liệu pháp tế bào CAR T nhắm CD19 không cần giảm lympho bào cho thấy triển vọng ở pemphigus vulgaris: góc nhìn từ thử nghiệm RESET-PV https://news.medxy.ai/cd19-car-t-cell-therapy-without-lymphodepletion-shows-promise-in-pemphigus-vulgaris-insights-from-the-reset-pv-trial/Medxy AIen2026-08-02T19:55:54-07:00CD19 CAR T-cell Therapy Without Lymphodepletion Shows Promise in Pemphigus Vulgaris: Insights from the RESET-PV Trial https://news.medxy.ai/zh/prognostic-of-moderate-exacerbation-in-copd-patients-insights-from-12-year-mortality/Medxy AIzh2026-08-02T18:47:35-07:00COPD患者单次中度急性加重的预后意义：基于12年死亡结局与未来急性加重风险的分析 https://news.medxy.ai/ja/prognostic-of-single-moderate-exacerbation-in-copd-patients-insights-from-12-year-mortality/Medxy AIja2026-08-02T18:47:14-07:00COPDにおける「1回の中等度増悪」が示す予後への影響――12年死亡データと将来増悪リスク解析から見えること https://news.medxy.ai/vi/prognostic-impact-of-single-moderate-exacerbation-in-copd-patients-insights-from-12-year-mortality/Medxy AIvi2026-08-02T18:46:51-07:00Ý nghĩa tiên lượng của một đợt kịch phát mức độ trung bình đơn lẻ ở bệnh nhân COPD: Góc nhìn từ phân tích tử vong 12 năm và nguy cơ kịch phát trong tương lai https://news.medxy.ai/prognostic-impact-of-single-moderate-exacerbation-in-copd-patients-insights-from-12-year-mortality-and-future-exacerbation-risk-analysis/Medxy AIen2026-08-02T18:45:37-07:00Prognostic Impact of Single Moderate Exacerbation in COPD Patients: Insights from 12-Year Mortality and Future Exacerbation Risk Analysis https://news.medxy.ai/ja/acute-exacerbation-in-fibrotic-interstitial-lung-disease/Medxy AIja2026-08-02T15:50:30-07:00線維性間質性肺疾患の急性増悪：2026年国際ワーキンググループ報告の重要提言 https://news.medxy.ai/zh/acute-exacerbation-in-fibrotic-interstitial-lung-disease-key-recommendations/Medxy AIzh2026-08-02T15:49:36-07:00纤维化性间质性肺疾病急性加重：2026年国际工作组报告的核心建议 https://news.medxy.ai/acute-exacerbation-in-fibrotic-interstitial-lung-disease-key-recommendations-from-the-2026-international-working-group-report/Medxy AIen2026-08-02T15:47:12-07:00Acute Exacerbation in Fibrotic Interstitial Lung Disease: Key Recommendations from the 2026 International Working Group Report